604 results on '"Bensen, Jeannette T."'
Search Results
2. The impact of marital status on tumor aggressiveness, treatment, and screening among black and white men diagnosed with prostate cancer
3. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
4. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24
5. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.
6. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.
7. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
8. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry
9. Question prompt lists and caregiver question asking in pediatric specialty appointments: A randomized controlled trial
10. Lessons learned while starting multi-institutional genetics research in diverse populations: A report from the Clinical Sequencing Evidence-Generating Research (CSER) consortium
11. Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP)
12. The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations
13. Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry
14. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
15. Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium
16. The motivation and process for developing a consortium‐wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care
17. The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study
18. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial
19. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
20. Dietary patterns based on the Mediterranean diet and DASH diet are inversely associated with high aggressive prostate cancer in PCaP
21. The motivation and process for developing a consortium‐wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care.
22. Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life
23. Frailty and health-related quality of life in older women with breast cancer
24. Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients
25. The Burden of COVID-19 on Caregivers of Children with Suspected Genetic Conditions: A Therapeutic Odyssey
26. Abstract 3508: Association between clonal hematopoiesis and risk of prostate cancer in a large sample of African ancestry men
27. Abstract 1182: Association of prostate cancer candidate genes with overall and aggressive prostate cancer in men of African ancestry
28. The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study
29. Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis
30. Activities, function, and health-related quality of life (HRQOL) of older adults with cancer
31. Perioperative sexual interest in women with suspected gynecologic malignancies
32. Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach
33. Supplementary Table S3 from Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry
34. Data from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
35. Supplementary Table 4 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
36. Supplementary Table 6 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
37. Supplementary Table 1 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
38. Characteristics of statin users and non-users, stratified by race from Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project
39. Supplementary Fig Leg from Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry
40. Supplementary Methods1 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
41. Associations between statin use and prostate cancer aggressiveness, overall and stratified by race and additionally adjusted for education, income and family history of prostate cancer. from Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project
42. Supplemental Figure 3 from Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors
43. Supplemental Figures from Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors
44. Supplementary Table 3 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
45. Supplementary Table 5 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
46. Supplemental Figure 1 from Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors
47. Supplemental Tables from Prediagnostic Smoking Is Associated with Binary and Quantitative Measures of ER Protein and ESR1 mRNA Expression in Breast Tumors
48. Supplementary Tables 1 - 8 from Single-Nucleotide Polymorphisms in Nucleotide Excision Repair Genes, Cigarette Smoking, and the Risk of Head and Neck Cancer
49. Associations between statin use, dose and type and prostate cancer aggressiveness, overall and stratified by race, excluding men who were using non-statin cholesterol-lowering drugs. from Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project
50. Supplementary Table 2 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.